Benzenesulfonamido and related compounds for use as agonists of RORγ and the treatment of disease
US10189777B2 · kind B2 · utility
2Cited by
55References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 5, 2015 |
| Grant date | Jan 29, 2019 |
| Priority date | — |
| Expiry date | May 5, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2602/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides benzenesulfonamido and related compounds, pharmaceutical compositions, methods of promoting RORγ activity, increasing the amount of IL-17 in a subject, and treating cancer using such benzenesulfonamido and related compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.